June 29, 2020 / 9:25 PM / 13 days ago

BRIEF-VistaGen Announces Strategic Partnership With EverInsight Therapeutics For Up To $177 Million

June 29 (Reuters) - VistaGen Therapeutics Inc:

* VISTAGEN THERAPEUTICS REPORTS FISCAL YEAR 2020 RESULTS AND PROVIDES CNS PIPELINE UPDATE

* VISTAGEN THERAPEUTICS INC - ANNOUNCES STRATEGIC PARTNERSHIP WITH EVERINSIGHT THERAPEUTICS FOR UP TO $177 MILLION IN UPFRONT & POTENTIAL MILESTONE PAYMENTS

* VISTAGEN THERAPEUTICS INC - DEVELOPING THREE DIFFERENTIATED, PATENT-PROTECTED, CNS PRODUCT CANDIDATES

* VISTAGEN THERAPEUTICS INC - CO & EVERINSIGHT THERAPEUTICS ENTERED INTO PARTNERSHIP FOR PHASE 3 CLINICAL DEVELOPMENT & COMMERCIALIZATION OF PH94B

* VISTAGEN THERAPEUTICS INC - AT MARCH 31, 2020, VISTAGEN HAD CASH AND CASH EQUIVALENTS OF $1.4 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below